StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Appoints Matthew J. Pietras as CFO and COO

<< Previous

Bullboard Posts

Next >>

Comment by LithLoveron Aug 04, 2021 10:14am

120 Views

Post# 33647824

RE:RE:RE:Appoints Matthew J. Pietras as CFO and COO

In The Q & A Rebecca states that additional board members/directors will be brought on with the closing of the deal.

"The Board of SZLS will undergo significant change over the next few months. The addition of Health Clinics/Care Oncology Directors will occur after the acquisition has closed. In addition to this, SZLS is intending to ensure the Board is fully reflective of the diversity in the marketplace"